Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbae102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 20.08.2024. Verfasst von Bingyi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: JinFeng Laboratory, Chongqing 401329, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Innovation Project of JinFeng Laboratory, Chongqing, China.
Abstract (Originalsprache)
Atherosclerosis (AS), an inflammatory disease characterized by lipid accumulation, has a high global incidence and mortality rate. Recently, nanotherapeutic approaches that target pathological sites and improve drug bioavailability and biocompatibility hold great promise for AS treatment. In this study, a biomimetic ROS-responsive hyaluronic acid–based nanomaterial was prepared for targeted anti-AS. Specifically, a safe ROS-responsive carrier based on hyaluronic acid (HSP) was prepared to load methotrexate (MTX), a drug known for its ability to enhance lipid excretion, resulting in the formation of MTX-loaded nanoparticles (MTXNPs). Furthermore, the macrophage membrane was coated on the surface of MTXNPs to obtain MM/MTXNPs. Both MTXNPs and MM/MTXNPs exhibited ROS responsiveness and demonstrated excellent biocompatibility. In vitro experiments revealed that MM/MTXNPs could evade macrophage phagocytosis and exhibited high uptake rates by inflamed endothelial cells. MM/MTXNPs also reduced lipid accumulation in foam cells. In vivo experiments showed that MM/MTXNPs exhibited superior accumulation at AS plaque sites, facilitated by the surface membrane layer containing integrin α4β1 and CD47, resulting in an enhanced therapeutic effect in inhibiting plaque development compared to free MTX and MTXNPs. Therefore, HSP represents a promising nanocarrier to load hydrophobic MTX, enabling effective and biocompatible enhancement of AS treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- JinFeng Laboratory, Chongqing 401329, China.
- Chongqing University Cancer Hospital, Chongqing 400030, China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400030, Ch…
- College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Förderung
- Science and Technology Innovation Project of JinFeng Laboratory, Chongqing, China
Zitieren
APA
Li, B., He, M., Xu, Z., Zhang, Q., Zhang, L., Zhao, S., Cao, Y., Mou, N., Wang, Y., & Wang, G. (2024). Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbae102
Vancouver
Li B, He M, Xu Z, Zhang Q, Zhang L, Zhao S, et al. Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbae102
BibTeX
@article{Li2024,
author = {Li, Bingyi and He, Mei and Xu, Zichen and Zhang, Qianting and Zhang, Liyuan and Zhao, Shuang and Cao, Yu and Mou, Nianlian and Wang, Yi and Wang, Guixue},
title = {Biomimetic ROS-responsive hyaluronic acid nanoparticles loaded with methotrexate for targeted anti-atherosclerosis},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbae102}
}
EUVIMED